PDCD1 and neoplasm: Statistically significant (P < 0.0001) differences in tumor growth could be recorded as early as day 13 in the NextA (55.83 mm3) and NextA/anti-PD-1 (34.35 mm3) groups and at day 15 in the anti-PD-1 group (299.1 mm3).